Literature DB >> 19643052

Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009.

N Komiya1, Y Gu, H Kamiya, Y Yahata, T Matsui, Y Yasui, N Okabe.   

Abstract

This report describes the clinical characteristics of influenza A(H1N1)v virus infection in Osaka. By the end of May, 171 cases had been reported in Osaka. Most patients were from one school. No patient had a serious underlying medical condition.Clinical symptoms were mild and resembled those of seasonal influenza. The sensitivity of the rapid antigen test was 77%. Antivirals were given to the majority of the cases. Early antiviral treatment may have shortened the duration of fever.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19643052     DOI： 10.2807/ese.14.29.19272-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  12 in total

Review 1.  Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.

Authors:  Nancy Santesso; Jonathan Hsu; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

Review 2.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

Review 3.  Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.

Authors:  Charles R Beck; Rachel Sokal; Nachiappan Arunachalam; Richard Puleston; Anna Cichowska; Anthony Kessel; Maria Zambon; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 4.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616

5.  Early clinical experiences with the new influenza A (H1N1/09).

Authors:  Ralf Winzer; Nicolas Kanig; Sophie Schneitler; Stefan Reuter; Björn Jensen; Irmela Müller-Stöver; Jun Oh; Ortwin Adams; Ertan Mayatepek; Hartmut Hengel; Heiko Schneitler; Dieter Häussinger
Journal:  Dtsch Arztebl Int       Date:  2009-11-20       Impact factor: 5.594

6.  Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.

Authors:  Wei Cui; Hongwen Zhao; Xu Lu; Ying Wen; Ying Zhou; Baocheng Deng; Yu Wang; Wen Wang; Jian Kang; Pei Liu
Journal:  BMC Infect Dis       Date:  2010-05-31       Impact factor: 3.090

7.  The role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus.

Authors:  Cemil Göya; Alpaslan Yavuz; Cihad Hamidi; Mehmet Güli Cetinçakmak; Memik Teke; Salih Hattapoğlu; Abdurrahim Duşak
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

8.  Pandemic (H1N1) 2009 transmission during presymptomatic phase, Japan.

Authors:  Yoshiaki Gu; Nobuhiro Komiya; Hajime Kamiya; Yoshinori Yasui; Kiyosu Taniguchi; Nobuhiko Okabe
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

9.  The novel influenza A (H1N1) virus pandemic: An update.

Authors:  N Petrosillo; S Di Bella; C M Drapeau; E Grilli
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

10.  Pandemic influenza virus surveillance, Izu-Oshima Island, Japan.

Authors:  Tomoko Inamasu; Kouji Sudo; Shingo Kato; Hiroshi Deguchi; Manabu Ichikawa; Tadanori Shimizu; Tadami Maeda; Shuhei Fujimoto; Toru Takebayashi; Tomoya Saito
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.